|
April. 14, 2026 |
|
|
Sept. 10, 2026 |
|
|
jRCT2052260022 |
N/A (N/A) |
|
N/A |
Koichiro Kinugawa |
||
Toyama University Hospital |
||
2630 Sugitani,Toyama-shi,Toyama,Japan |
||
+81-76-434-2315 |
||
kinugawa0422@gmail.com |
||
Okamoto Etsuro |
||
Abbott Medical Japan |
||
1-5-2 Higashi Shimbashi, Minato |
||
+81-76-434-2315 |
||
etsuro.okamoto@abbott.com |
Not Recruiting |
Mar. 02, 2026 |
||
| Mar. 02, 2026 | ||
| 250 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1)The patient must be eligible to receive the TriClip System per the current approved indications for use, and |
||
NA |
||
| No limit | ||
| No limit | ||
Both |
||
symptomatic severe tricuspid regurgitation |
||
Interventional tricuspid valve repair |
||
TR |
||
TriClip |
||
D014262 |
||
(1) Moderate or less TR at 30-day visit. |
||
NA |
||
| Abbott Medical Japan |
| Abbott Medical Japan |
| The National Cardiovascular Research Center IRB | |
| 6-1 Shinmachi Kishibe, Suita, Osaka, Osaka | |
+81-570-012-545 |
|
Dec. 22, 2025 |
No |
None |